The majority of EU5 physicians today participate in congresses sponsored by pharmaceutical companies. With such a large HCP audience available for marketers to engage, it is critical to understand the depth of the opportunity and the tactics necessary to maximize impact via the congress channel. This report explores the nuances that come into play as pharma marketers seek to promote sponsored congresses with meaningful content to EU5 physicians at the country level.